India

In 2016, Solidarity and Action Against the HIV Infection in India (SAATHII) began a partnership with Janssen Global Public Health, an initiative of the Janssen Pharmaceutical Companies of Johnson & Johnson. The initiative, named m-Maitri, aimed to complement on-the-ground efforts at ensuring retention in the Prevention of Parent to Child Transmission (PPTCT) cascade with Interactive Voice Response (IVR) to consenting pregnant women and mother-baby pairs until the babies reach 18 months of age.

 

TB is second only to HIV as a killer infectious disease, with more than 10 million new infections in 2015 and an estimated 1.8 million deaths mostly in low- and middle-income countries.In many countries, the private sector represents a major and growing source of services for suspected and active cases of TB. This often presents a challenge for national health systems that are ill-equipped to ensure that private providers provide safe and effective care.

As a follow up to the India Newborn Action Plan, the Haryana Newborn Action Plan (HNAP) has been drafted as a state-specific roadmap for reducing preventable newborn deaths and stillbirths and achieving the desired targets for the neonatal mortality rate (NMR) and stillbirth rate (SBR) by 2030.

This brochure describes USAID’s flagship project VRIDDHI which provides techno-managerial support to the Ministry of Health and Family Welfare, Government of India and the state governments of Delhi, Haryana, Himachal Pradesh, Jharkhand, Punjab, and Uttarakhand to plan, implement and monitor RMNCH+A interventions at scale.

Pages